Probability of detecting germline BRCA1/2 pathogenic variants in histological subtypes of ovarian carcinoma. A meta-analysis-Reference-Cited by-同舟云学术

Probability of detecting germline BRCA1/2 pathogenic variants in histological subtypes of ovarian carcinoma. A meta-analysis

Published:2022-01 Issue:1 Volume:164 Page:221-230
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Witjes Vera M.,van Bommel Majke H.D.,Ligtenberg Marjolijn J.L.,Vos Janet R.,Mourits Marian J.E.,Ausems Margreet G.E.M.,de Hullu Joanne A.,Bosse Tjalling,Hoogerbrugge Nicoline

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Oncology

Reference62 articles.

1. Inherited mutations in women with ovarian carcinoma;Norquist;JAMA Oncol.,2016

2. Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing;Walsh;Proc. Natl. Acad. Sci. U. S. A.,2011

3. Association of breast and ovarian cancers with predisposition genes identified by large-scale sequencing;Lu;JAMA Oncol.,2019

4. Rare germline genetic variants and the risks of epithelial ovarian cancer;Pavanello;Cancers,2020

5. Large-scale meta-analysis of mutations identified in panels of breast/ovarian cancer-related genes - providing evidence of cancer predisposition genes;Suszynska;Gynecol. Oncol.,2019

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of molecular testing on the surgical management of advanced epithelial ovarian cancer;Critical Reviews in Oncology/Hematology;2024-10

2. Factors associated with an inconclusive result from commercial homologous recombination deficiency testing in ovarian cancer;Cancer;2024-08-16

3. Risk-reducing salpingectomy with delayed oophorectomy to prevent ovarian cancer in women with an increased inherited risk: insights into an alternative strategy;Familial Cancer;2024-06-21

4. Association Between Germline BRCA1/2 Gene Variants and Clinicopathological Features of Ovarian Cancer;International Journal of General Medicine;2024-01

5. Predictive and prognostic biomarkers in female genital tract tumours: an update highlighting their clinical relevance and practical issues;Pathology;2023-12